XML 45 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Licensed rights and other intangible assets (Tables)
9 Months Ended
Sep. 30, 2022
Goodwill And Intangible Assets Disclosure [Abstract]  
Summary of Information about License Rights and Other Intangible Assets, Net

The following provides information about our license rights and other intangible assets, net (in thousands):

 

 

September 30, 2022

 

 

December 31, 2021

 

 

 

Gross

 

 

 

 

 

 

 

 

 

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Carrying

 

 

Accumulated

 

 

 

 

 

 

Carrying

 

 

Accumulated

 

 

 

 

 

 

 

Amount

 

 

Amortization

 

 

Net

 

 

Amount

 

 

Amortization

 

 

Net

 

Licensed rights and intangible assets

   subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

License rights

 

$

40,000

 

 

$

9,086

 

 

$

30,914

 

 

$

40,000

 

 

$

6,826

 

 

$

33,174

 

Hormone therapy drug patents

 

 

6,189

 

 

 

1,484

 

 

 

4,705

 

 

 

5,834

 

 

 

1,042

 

 

 

4,792

 

Hormone therapy drug patents applied

   and pending approval

 

 

1,936

 

 

 

 

 

 

1,936

 

 

 

2,020

 

 

 

 

 

 

2,020

 

License rights and other intangible assets

   subject to amortization

 

 

48,125

 

 

 

10,570

 

 

 

37,555

 

 

 

47,854

 

 

 

7,868

 

 

 

39,986

 

Intangible assets not subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trademarks/trade name rights

 

 

321

 

 

 

 

 

 

321

 

 

 

332

 

 

 

 

 

 

332

 

License rights and other intangible assets, net

 

$

48,446

 

 

$

10,570

 

 

$

37,876

 

 

$

48,186

 

 

$

7,868

 

 

$

40,318